Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0029463 (osteosarcoma)
 16,637 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Two mouse monoclonal antibodies (MoAbs), TP-1 and TP-3, previously shown in immunohistochemical studies to react with osteosarcomas, were labelled with 125I or 131I and evaluated for their ability to localise to human osteogenic sarcoma xenografts after intravenous injection. The radiolabelled TP-1 and TP-3 MoAbs had immunoreactive fractions of 70% and 67%, respectively, and bound to target cells with binding constants of 8.5 X 10(8) M-1 and 4.0 X 10(9) M-1, respectively. After injection of labelled TP-3 IgG, approximately 16% of the dose X g-1 tissue was found in the tumour after 24 hours. Maximum tumour/blood radioactivity ratios of 6-7 were achieved 3-4 days after antibody injection, while the ratios for the normal tissues were less than 1. The tumours could be clearly visualised by whole-body gamma scintigraphy without the need for subtraction techniques. The TP-1 IgG accumulated to a large extent also in the spleen. Hence, with this antibody the tumour was less well delineated from the adjacent normal tissues. However, the F(ab')2 fragments, derived from the TP-1 IgG, gave tumour/blood ratios up to approximately 40 after 3-4 days and yielded sharp gamma scintigrams of the tumour. Specificity of the antibody localisation was indicated by the lack of accumulation in a contralateral melanoma xenograft and the failure of 2 isotype-matched irrelevant MoAbs to localise to the sarcomas. With the F(ab')2 fragments satisfactory images could be obtained already after 16 hours. The results suggest that this preparation may be useful in clinical radioimmunodetection of osteogenic sarcomas.
 ...
PMID:Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts. 347 43

Electron-microscopic studies in which Alcian blue was used to demonstrate proteoglycans (PG) revealed a predominance of largely undifferentiated tumor cells in two of the osteosarcomas examined; the extracellular matrix of these tumors had few PG-containing structures. Other osteosarcomas, where cells of the osteoblastic type prevailed, were found to possess PG granules on the cell surface and a rough PG network in the pericellular space. In a parosteal osteosarcoma, which contained strongly elongated fibroblast-like cells, PG formed a fine mesh both in the pericellular space and throughout the extracellular matrix. A correlation therefore exists between the ultrastructure of the PG component in the extracellular matrix of osteogenic sarcomas and the degree and direction of tumor cell differentiation.
 ...
PMID:[Electron microscopic detection of the proteoglycan component of the extracellular matrix in osteogenic sarcomas]. 347 6

The authors studied 19 patients with well documented osteogenic sarcomas arising in the skull, which represent 1.6% of all osteogenic sarcomas registered during a 60-year period (1921-1981). Ten sarcomas were primary, de novo tumors. Nine others developed secondary osteogenic sarcomas; among these, six arose as a complication of Paget's disease, two followed irradiation, and one was associated with pre-existent fibrous dysplasia. The sarcomas arose in equal proportion in both sexes with the men being much older (mean age, 44 years) as compared to the women (mean age, 31 years). Patients with de novo osteogenic sarcomas were considerably younger than those with secondary lesions. Osteoblastic osteogenic sarcoma was by far the most common histologic variant in both the primary and the Paget's sarcomas. None of the patients with Paget's sarcoma lived longer than 1 year; the median survival here was 4 months. Patients with de novo osteogenic sarcomas fared much better and there are four long-term survivors (longer than 3 years) who are currently disease-free.
 ...
PMID:Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. 386 Feb 81

Sarcoma as a second malignant neoplasm following radiotherapy is a rare occurrence in childhood. A case of osteogenic osteosarcoma of temporoparietal bone that developed 56 months after irradiation for a cerebellar astrocytoma in a 10-year-old child is reported and the pertinent literature is briefly reviewed. The possibility of an association (in the same patient) between these two rather uncommon lesions is extremely unlikely. Therefore, it is possible that radiotherapy played a role in the induction of the sarcoma. The indolent course of the latter is stressed.
 ...
PMID:Osteogenic osteosarcoma of the calvaria following radiotherapy for cerebellar astrocytoma: report of a case in childhood. 386 55

Extraosseous osteogenic sarcomas are unusual tumors that are seldom diagnosed. Although primary renal osteogenic sarcoma has been reported, and is described in the Armed Forces Institute of Pathology fascicle, most clinicians are unaware of its existence. We describe a patient with this disease to remind clinicians of this tumor, its presentation and rapid evolution.
 ...
PMID:Primary osteosarcoma of kidney with liposarcomatous elements. 388 24

The sequential cellular changes in the implants in response to collagenous bone matrix-induced local bone formation include: binding of fibronectin to matrix, chemotaxis and attachment of progenitor cells, proliferation and differentiation of progenitor cells into chondrocytes, and finally osteogenesis and marrow differentiation. The cellular origin of osteogenic proteins is not clear. The present study compares the osteogenic potential of demineralized rat and porcine bone matrix by dissociative extraction and reconstitution. Judging from the Sephacryl S-200 gel filtration profiles of the dissociative extracts of rat and porcine matrix, the latter appears to be smaller. Under identical experimental conditions, the rat chondrosarcoma and osteosarcoma were examined for chondrogenic and osteogenic properties and found to be devoid of inductive potential. It is noteworthy that gel filtration fractions of rat chondrosarcoma on Sepharose CL-6B are inhibitory to bone inductive potential of demineralized rat bone matrix.
 ...
PMID:Bone matrix-induced local bone induction. 390 7

Primary malignant bone tumors, osteosarcomas (9 cases), and Ewing's sarcomas (10 cases) were examined for their reactivities with monoclonal and polyclonal antibodies against filamentous proteins and cell membrane determinants of the lymphoid and macrophage marker series. The reactivity of antibodies was studied on snap-frozen tissue probes by using a triple layer immunoperoxidase method. Osteosarcomas were positive for vimentin and, in part, for HLA-DR. Other types of intermediate-sized filaments were not detected in tumour cells. In a small number of cases (2/9) tumour cells were reactive with antibodies of the macrophage series (Leu M2). In Ewing's sarcomas, vimentin and HLA-DR was also demonstrated. It was particularly interesting that Leu M2 staining was found in the majority of cases (8/10). The staining pattern supports the assumption that this peculiar tumour is of mesenchymal (monocyte/macrophage) histogenesis. It was evident from the present study that, in primary osteogenic tumors, none of the examined tumour "markers" were as distinctive as they are for bone metastases. Nevertheless, the reactivity of Ewing's sarcoma cells with monoclonal antibodies of the Leu M2 type throws some highlights on the, as yet, obscure histogenesis of the neoplasm and may be of diagnostic value in conjunction with the known light and electron microscope features of the tumour.
 ...
PMID:Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants. 392 63

Two out of 9 weanling hamsters, treated with intravenous inoculation of highly concentrated human papovavirus BK, propagated in human embryonic kidney cells, developed osteogenic sarcomas of the costal cage and the mandibula. The sera of the tumor-bearing animals were positive for BK T-antigen and the successively transplanted tumors were positive for intranuclear T-antigen when tested with anti-SV40 T-antibody by immunofluorescence. The tumor tissue exhibited various stages of maturation, from areas showing immature sarcoma and angiomatous sarcoma to those of well-differentiated osteogenic sarcoma. Tumor histology was described in detail.
 ...
PMID:Characteristics of osteogenic sarcoma of hamsters induced by BK virus. 624 35

Almost all malignant bone tumors in children are either osteogenic sarcomas or Ewing's sarcomas. Their origin and their site are different as well as the course of the disease and its treatment. Amputation or desarticulation in still the best local treatment for osteogenic sarcoma. Irradiation can benefit some patients. Conservative resection, followed by internal prosthesis, is still an experimental procedure. Results of chemotherapy combining high-dose methotrexate and adriamycin have been controversial. Prophylactic pulmonary irradiation seems to lessen the number of metastases. Controlled therapeutic trials are mandatory to assess the efficacy of these complementary treatments. Local cure is obtained in 90% of Ewing's sarcomas by high doses of radiotherapy but with a number of late sequellae. This tumor is also highly chemosensitive. Treatment of the infra-clinical disease by intensive chemotherapy has significantly increased the number of long-term cures. Other therapeutic regimens combining chemotherapy, radiotherapy and limited conservative surgery are now under investigation in an effort to diminish the sequellae without decreasing the number of cures.
 ...
PMID:[Malignant bone tumors in children (author's transl)]. 627 17

Twenty-nine patients with osteogenic osteosarcoma of a limb underwent both pulmonary radiotherapy and chemotherapy immediately after treatment of the primary tumor, mainly by radical surgery or radiotherapy (80 grays/tumor). Chemotherapy consisted of alternate A and B cycles every four weeks and BCG scarifications between cycles. Cycle A combines vincristine, ameticine, methotrexate and folinic acid; cycle B consists of adriamycin, vincristine, imidazole carboxamide and cyclophosphamide. A 20 gray irradiation was delivered to the thorax between the first A and B cycles. 50% of patients had no local recurrence or metastases after three years. 70% are alive at three years. Toxicity of this protocol is mainly hematologic and bronchopulmonary (with one fatal infection). Alopecia and minor digestive toxicity were recorded in all patients. Severe cardiotoxicity was seen in only one case. Longer follow-up is needed to evaluate long-term toxicity, particularly bronchopulmonary side-effects.
 ...
PMID:[Adjuvant therapy of osteogenic osteosarcomas of the limb: results of the SO4 78 trial]. 629 Nov 57


<< Previous 1 2 3 4 5 6 7 8 9 10